The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Open accessAbstract
Glioblastomas are lethal cancers characterized by florid angiogenesis promoted in part by glioma stem cells (GSCs). Because hypoxia regulates angiogenesis, we examined hypoxic responses in GSCs. We now demonstrate that hypoxia-inducible factor HIF2alpha and multiple HIF-regulated genes are preferentially expressed in GSCs in comparison to non-stem tumor cells and normal neural progenitors. In tumor specimens, HIF2alpha colocalizes with cancer stem cell markers. Targeting HIFs in GSCs inhibits self-renewal, proliferation, and survival in vitro, and attenuates tumor initiation potential of GSCs in vivo. Analysis of a molecular database reveals that HIF2A expression correlates with poor glioma patient survival. Our results demonstrate that GSCs differentially respond to hypoxia with distinct HIF induction patterns, and HIF2alpha might represent a promising target for antiglioblastoma therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since HIF-2α is strongly expressed in the cytoplasm of NB tumor cells at physiological oxygen levels (5% O2), this could suggest additional largely unexplored functions of HIF-2α in the cytoplasm, independent of HIF-1β-dependent transcription, such as regulation of mRNA translation [9,43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In NB clinical specimens, HIF-1α expression negatively correlates with the presence of blood vessels indicating that HIF-1α is expressed exclusively in hypoxic cells [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, HIF-2α is located in dense clusters of cells adjacent to blood vessels, referred to as the perivascular niche, which have a neural crest-like phenotype, and are HIF-1α negative, suggesting they are not hypoxic [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, treatment with PT2385 had no effect on tumor growth, did not impact transcription of HIF target genes and did not modulate chemotherapy response [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“Given that HIF-2α is an important transcription factor in cancer progression and leads to poor prognosis69,70”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [70]
In the citing paper
“Hypoxia was first shown to induce the CSC phenotype in glioma [77] and, subsequently, in breast cancer [78, 79], in a HIF-dependent manner.”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517
Self-citationHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., Vitis, S. D., Fiocco, R., Foroni, C., DiMeco, F., & Vescovi, A. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,262
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D. K., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,844
Cancerous stem cells can arise from pediatric brain tumors
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M. D., Geschwind, D. H., Bronner-Fraser, M. E., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,842
Flagged first, then by citations
1 of the 65 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,000
Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth
Sighel, D., Notarangelo, M., Aibara, S., Re, A., Ricci, G., Guida, M., Soldano, A., Adami, V., Ambrosini, C., Broso, F., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109024 · Cited by 71
Nishikawa, M., Inoue, A., Ohnishi, T., Kohno, S., Ohue, S., Matsumoto, S., Suehiro, S., Yamashita, D., Ozaki, S., Watanabe, H., et al. (2018) · Stem Cells International · doi:10.1155/2018/5387041 · Cited by 69
Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features
Ballestín, A., Armocida, D., Ribecco, V., & Seano, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1347877 · Cited by 70
Daniele, S., Zappelli, E., Natali, L., Martini, C., & Trincavelli, M. L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.487 · Cited by 69
HSP90 Inhibitor 17-AAG Selectively Eradicates Lymphoma Stem Cells
Newman, B. W., Liu, Y., Lee, H.-F., Sun, D., & Wang, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3600 · Cited by 68
Hippo pathway and breast cancer stem cells
Maugeri‐Saccà, M., & Maria, R. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.12.004 · Cited by 70
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells
Tate, C. M., D, R. P. M., Ricci‐Vitiani, L., Dowless, M. S., Shiyanova, T. L., D’Alessandris, Q. G., Morgante, L., Giannetti, S., Larocca, L. M., Martino, S. D., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.44 · Cited by 67
Hypoxia and cancer related pathology
Xiong, Q., Liu, B., Ding, M., Zhou, J., Yang, C., & Chen, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.002 · Cited by 71
El‐Tanani, M., Rabbani, S. A., Satyam, S. M., Rangraze, I. R., Wali, A. F., El‐Tanani, Y., & Aljabali, A. A. A. (2025) · Cancers · doi:10.3390/cancers17030382 · Cited by 67
Piccirillo, S. G. M., Binda, E., Fiocco, R., Vescovi, A. L., & Shah, K. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0535-3 · Cited by 67
Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma
Yao, H., Liu, N., Lin, M. C.-M., & Zheng, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.014 · Cited by 67
Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells
Bayin, N. S., Frenster, J. D., Sen, R., Si, S., Modrek, A. S., Galifianakis, N., Dolgalev, I., Ortenzi, V., Illa-Bochaca, I., Khahera, A. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18117 · Cited by 67
Mao, X., Xue, X., Lv, R., Ji, A., Shi, T., Chen, X.-Y., Jiang, X., & Zhang, X. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05788-y · Cited by 66
Insight into the complex regulation of CD133 in glioma
Campos, B., & Herold‐Mende, C. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25687 · Cited by 66
Decreased Expression of Cystathionine β-Synthase Promotes Glioma Tumorigenesis
Takano, N., Sarfraz, Y., Gilkes, D. M., Chaturvedi, P., Xiang, L., Suematsu, M., Zagzag, D., & Semenza, G. L. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0184 · Cited by 66
Wang, X., Dai, X., Zhang, X., Ma, C., Li, X., Xu, T., & Lan, Q. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36549 · Cited by 66
Hasmim, M., Noman, M. Z., Lauriol, J., Benlalam, H., Mallavialle, A., Rosselli, F., Mami‐Chouaib, F., Alcaïde‐Loridan, C., & Chouaı̈b, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101011 · Cited by 65
Chromosomal Instability Affects the Tumorigenicity of Glioblastoma Tumor-Initiating Cells
Godek, K. M., Venere, M., Wu, Q., Mills, K. D., Hickey, W. F., Rich, J. N., & Compton, D. A. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1154 · Cited by 68
Self-citationEliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways
Oren, O., & Smith, B. D. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9691-3 · Cited by 65
Liu, T., Karlsen, M., Karlberg, A. M., & Redalen, K. R. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00621-5 · Cited by 65
Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells
Berg, T. J., & Pietras, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.011 · Cited by 64
Janoušková, O., Herma, R., Semerádtová, A., Poustka, D., Liegertová, M., Malinská, H. A., & Malý, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.846650 · Cited by 64
ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres
Kahlert, U. D., Suwala, A. K., Raabe, E. H., Siebzehnrübl, F. A., Suarez, M. J., Orr, B. A., Bar, E. E., Maciaczyk, J., & Eberhart, C. G. (2014) · Brain Pathology · doi:10.1111/bpa.12240 · Cited by 66
Inhibition of EGFR Induces a c-MET-Driven Stem Cell Population in Glioblastoma
Jun, H. J., Bronson, R. T., & Charest, A. (2013) · Stem Cells · doi:10.1002/stem.1554 · Cited by 64
Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth
Verginelli, F., Perin, A., Dali, R., Fung, K. H. M., Lo, R., Longatti, P., Guiot, M. C., Maestro, R. F. D., Rossi, S., di Porzio, U., et al. (2013) · Nature Communications · doi:10.1038/ncomms3956 · Cited by 65
Peng, G., Wang, Y., Ge, P., Bailey, C. M., Zhang, P., Zhang, D., Meng, Z., Qi, C., Chen, Q., Chen, J., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02082-7 · Cited by 63
Ye, F., Zhang, Y., Liu, Y., Yamada, K., Tso, J. L., Menjivar, J. C., Tian, J. Y., Yong, W. H., Schaue, D., Mischel, P. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080397 · Cited by 63
Mimeault, M., & Batra, S. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.08.001 · Cited by 65
Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages
Penn, C. A., Yang, K., Zong, H., Lim, J. Y., Cole, A., Yang, D., Baker, J. R., Goonewardena, S. N., & Buckanovich, R. J. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0688 · Cited by 64
Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma
Olmez, I., Zhang, Y., Manigat, L. C., Benamar, M., Brenneman, B. R., Nakano, I., Godlewski, J. A., Bronisz, A., Lee, J., Abbas, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3124 · Cited by 66
Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma
Wang, S., Qi, Y., Gao, X. C., Qiu, W., Liu, Q., Guo, X., Qian, M., Chen, Z., Zhang, Z., Wang, H., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2345-z · Cited by 62
Self-citationRochette, L., Mazini, L., Malka, G., Zeller, M., Cottin, Y., & Vergely, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239262 · Cited by 65
Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy
Rouzbahani, E., Majidpoor, J., Najafi, S., & Mortezaee, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113906 · Cited by 62
Han, Z., Wang, X., Ma, L., Chen, L., Xiao, M., Huang, L., Cao, Y., Bai, J., Ma, D., Zhou, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2314 · Cited by 63
Self-citationde Silly, R. V., Ducimetière, L., Maroun, C. Y., Dietrich, P., Derouazi, M., & Walker, P. R. (2015) · European Journal of Immunology · doi:10.1002/eji.201445284 · Cited by 62
Improving the Radiosensitivity of Radioresistant and Hypoxic Glioblastoma
Sheehan, J. P., Shaffrey, M. E., Gupta, B., Larner, J. M., Rich, J. N., & Park, D. M. (2010) · Future Oncology · doi:10.2217/fon.10.123 · Cited by 66
Self-citationWerner, B., Scott, J. G., Sottoriva, A., Anderson, A. R. A., Traulsen, A., & Altrock, P. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2069 · Cited by 62
NOS Expression and NO Function in Glioma and Implications for Patient Therapies
Tran, A. N., Boyd, N., Walker, K. D., & Hjelmeland, A. B. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6820 · Cited by 62
Self-citationHypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease
Hasegawa, S., Tanaka, T., & Nangaku, M. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000431 · Cited by 63
Meng, L., Wang, C., Lu, Y., Sheng, G., Yang, L., Wu, Z., Xu, H., Han, C., Lu, Y., & Han, F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00347 · Cited by 61
Glioblastoma Metabolism: Insights and Therapeutic Strategies
Bernhard, C., Reita, D., Martin, S., Entz‐Werlé, N., & Dontenwill, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119137 · Cited by 66
The cardiac hypoxic niche: emerging role of hypoxic microenvironment in cardiac progenitors.
Kimura, W., & Sadek, H. A. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2012.12.02 · Cited by 61
Lachance, G., Uniacke, J., Audas, T. E., Holterman, C. E., Franovic, A., Payette, J., & Lee, S. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322909111 · Cited by 62
Apoptotic Death of Cancer Stem Cells for Cancer Therapy
He, Y., Zhou, F., Shen, Y., Liao, D., & Cao, D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058335 · Cited by 60
Cellular and Molecular Mechanisms Underlying Oxygen-Dependent Radiosensitivity
Liu, C., Lin, Q., & Yun, Z. (2015) · Radiation Research · doi:10.1667/rr13959.1 · Cited by 63
Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cells
Ou, J., Deng, J., Wei, X., Xie, G., Zhou, R., Yu, L., & Liang, H. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.05.009 · Cited by 62
Fang, X., Huang, Z., Zhou, W., Wu, Q., Sloan, A. E., Ouyang, G., McLendon, R. E., Yu, J. S., Rich, J. N., & Bao, S. (2014) · Stem Cells · doi:10.1002/stem.1730 · Cited by 60
Self-citationAptamer Identification of Brain Tumor–Initiating Cells
Kim, Y., Wu, Q., Hamerlik, P., Hitomi, M., Sloan, A. E., Barnett, G. H., Weil, R. J., Leahy, P. S., Hjelmeland, A. B., & Rich, J. N. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4556 · Cited by 60
Self-citationThe dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
Cohen, P. A., Donini, C. F., Nguyen, N. T., Lincet, H., & Vendrell, J. A. (2015) · Oncotarget · doi:10.18632/oncotarget.5893 · Cited by 60
Ullmann, P., Qureshi-Baig, K., Rodriguez, F., Ginolhac, A., Nonnenmacher, Y., Ternes, D., Weiler, J., Gäbler, K., Bahlawane, C., Hiller, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11772 · Cited by 60
Anthocyanins ameliorate palmitate‐induced inflammation and insulin resistance in 3T3‐L1 adipocytes
Muscarà, C., Molonia, M. S., Speciale, A., Bashllari, R., Cimino, F., Occhiuto, C., Saija, A., & Cristani, M. (2019) · Phytotherapy Research · doi:10.1002/ptr.6379 · Cited by 65
Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior
Kumar, V. E., Nambiar, R., Souza, C. D., Nguyen, A. D., CHIEN, J. R., & Lam, K. S. (2022) · Cells · doi:10.3390/cells11091403 · Cited by 61
Gatza, M. L., Kung, H., Blackwell, K., Dewhirst, M. W., Marks, J. R., & Chi, J. (2011) · Breast Cancer Research · doi:10.1186/bcr2899 · Cited by 59
Regulation of vitamin metabolism by p53 and p63 in development and cancer
Zhou, H., & van Bokhoven, H. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12591 · Cited by 61
In vitro biomimetic models for glioblastoma-a promising tool for drug response studies
Stanković, T., Ranđelović, T., Dragoj, M., Burić, S. S., Fernández, L. J., Ochoa, I., Pérez‐García, V. M., & Pešić, M. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100753 · Cited by 62
S-Nitrosylation in Tumor Microenvironment
Sharma, V., Fernando, V., Letson, J., Walia, Y., Zheng, X., Fackelman, D., & Furuta, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094600 · Cited by 59
Eyme, K. M., Sammarco, A., Jha, R., Mnatsakanyan, H., Pechdimaljian, C., de Carvalho, L. A., Neustadt, R., Moses, C., Alnasser, A. A., Tardiff, D. F., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq6288 · Cited by 58
Pietras, A., Johnsson, A. S., & Påhlman, S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_72 · Cited by 62
Florio, T., & Barbieri, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.06.001 · Cited by 59
Bao, B., Azmi, A. S., Li, Y., Ahmad, A., Ali, S. S., Banerjee, S., Kong, D., & Sarkar, F. H. (2013) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x113089990053 · Cited by 60
Zhang, H., Wang, M.-D., Zhou, X., Qin, C., Fu, G., Tang, L., Wu, H., Huang, S., Zhao, L., Zeng, M., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.023 · Cited by 58
Self-citationThe Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells
Audia, A., Conroy, S., Glaß, R., & Bhat, K. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00143 · Cited by 59
PAF promotes stemness and radioresistance of glioma stem cells
Ong, D. S. T., Hu, B., Ho, Y. W., Sauvé, C.-E. G., Bristow, C. A., Wang, Q., Multani, A. S., Chen, P., Nezi, L., Jiang, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708122114 · Cited by 58
Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche
Linden, C. V., & Corbet, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00159 · Cited by 58
Jiang, Y., Zhou, J., Hou, D., Luo, P., Gao, H., Ma, Y., Chen, Y., Li, L., Zou, D., Zhang, H., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5278 · Cited by 58
Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors
Bielecki, P. A., Lorkowski, M. E., Becicka, W. M., Atukorale, P. U., Moon, T. J., Zhang, Y., Wiese, M. L., Covarrubias, G., Ravichandran, S., & Karathanasis, E. (2020) · Nanoscale Horizons · doi:10.1039/d0nh00446d · Cited by 58
Tumor Temperature: Friend or Foe of Virus-Based Cancer Immunotherapy
Knapp, J. P., Kakish, J. E., Bridle, B. W., & Speicher, D. J. (2022) · Biomedicines · doi:10.3390/biomedicines10082024 · Cited by 57
Faisal, S. M., Comba, A., Varela, M. L., Argento, A. E., Brumley, E. K., Abel, C. C., Castro, M. G., & Lowenstein, P. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005069 · Cited by 58
A Narrative Review on CD44’s Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence
Inoue, A., Ohnishi, T., Nishikawa, M., Ohtsuka, Y., Kusakabe, K., Yano, H., Tanaka, J., & Kunieda, T. (2023) · Cancers · doi:10.3390/cancers15194898 · Cited by 59
From stem cells to cancer stem cells: HIF takes the stage
Lee, K. E., & Simon, M. C. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.01.005 · Cited by 57
The hitchhikers guide to cancer stem cell theory: Markers, pathways and therapy
Fábián, Á., Vereb, G., & Szöllõsi, J. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22206 · Cited by 57
Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment
Noman, M. Z., Messai, Y., Muret, J. C., Hasmim, M., & Chouaı̈b, S. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0157-3 · Cited by 57
Type 3 Deiodinase: Role in Cancer Growth, Stemness, and Metabolism
Ciavardelli, D., Bellomo, M., Crescimanno, C., & Vella, V. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00215 · Cited by 57
Westerlund, I., Shi, Y., Toskas, K., Fell, S. M., Li, S., Surova, O. V., Södersten, E., Kogner, P., Nyman, U., Schlisio, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700655114 · Cited by 58
Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics
Sreepadmanabh, M., & Toley, B. J. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.009 · Cited by 58
Wang, P., Yan, Q., Liao, B., Zhao, L., Xiong, S., Wang, J., Zou, D., Pan, J., Wu, L., Deng, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03150-0 · Cited by 58
Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges
Piper, K. J., DePledge, L., Karsy, M. J., & Cobbs, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.615704 · Cited by 63
The role of tumor microenvironment on cancer stem cell fate in solid tumors
Razi, S., Haghparast, A., Khameneh, S. C., Sadrabadi, A. E., Aziziyan, F., Bakhtiyari, M., Nabi‐Afjadi, M., Tarhriz, V., Jalili, A., & Zalpoor, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01129-w · Cited by 56
Nanomedicine to overcome radioresistance in glioblastoma stem-like cells and surviving clones
Séhédic, D., Cikankowitz, A., Hindré, F., Davodeau, F., & Garcion, E. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.002 · Cited by 60
Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors
Bronisz, A., Godlewski, J. A., & Chiocca, E. A. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0293-4 · Cited by 57
Voss, D. M., Spina, R., Carter, D. L., Lim, K. S., Jeffery, C. J., & Bar, E. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-04612-w · Cited by 58
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Meel, M. H., Schaper, S. A., Kaspers, G. J. L., & Hulleman, E. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2714-7 · Cited by 58
O’Reilly, D., JOHNSON, P. A., & Buchanan, P. (2019) · Steroids · doi:10.1016/j.steroids.2019.108497 · Cited by 57
Metabolism in the progression and metastasis of brain tumors
Tyagi, A., Wu, S.-Y., & Watabe, K. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215713 · Cited by 59
Mun, J.-Y., Jabbar, A. A., Devi, N. S., Yin, S., Wang, Y., Tan, C., Culver, D. G., Snyder, J. P., Meir, E. G. V., & Goodman, M. M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300752n · Cited by 55
Mao, X., Yan, M., Xue, X., Zhang, X., Ren, H.-G., Guo, G., Wang, P., Zhang, W., & Huo, J. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.56 · Cited by 55
Velpula, K. K., Rehman, A. A., Chelluboina, B., Dasari, V. R., Gondi, C. S., Rao, J. S., & Veeravalli, K. K. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.002 · Cited by 55
Yin, B., Y, Z., Zhou, Z., Gao, W., Du, Z., Zhao, Z., & Li, Q.-Q. (2014) · Oncogene · doi:10.1038/onc.2014.8 · Cited by 55
Chemoresistance and Chemotherapy Targeting Stem-Like Cells in Malignant Glioma
Sørensen, M. D., Fosmark, D. S., Hellwege, S., Beier, D., Kristensen, B. W., & Beier, C. P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16537-0_7 · Cited by 55
Calinescu, A., Yadav, V. N., Carballo, E. V., Kadiyala, P., Tran, D., Zamler, D. B., Doherty, R. E., Srikanth, M., Lowenstein, P. R., & Castro, M. G. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2888 · Cited by 55
D’Alessio, A., Proietti, G., Lama, G., Biamonte, F., Lauriola, L., Moscato, U., Vescovi, A. L., Mangiola, A., Angelucci, C., & Sica, G. (2016) · Oncotarget · doi:10.18632/oncotarget.12398 · Cited by 57
Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells
Relation, T., Dominici, M., & Horwitz, E. M. (2017) · Stem Cells · doi:10.1002/stem.2596 · Cited by 55
Wu, Y.-C., Ling, T., Lu, S.-H., Kuo, H., Ho, H., Yeh, S.-D., Shen, C., & Huang, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0673 · Cited by 55
Integrating diverse genomic data using gene sets
Tyekucheva, S., Marchionni, L., Karchin, R., & Parmigiani, G. (2011) · Genome biology · doi:10.1186/gb-2011-12-10-r105 · Cited by 54
Isolation and Culture of Primary Glioblastoma Cells from Human Tumor Specimens
Seidel, S., Garvalov, B. K., & Acker, T. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1785-3_19 · Cited by 54
Boso, D., Rampazzo, E., Zanon, C., Bresolin, S., Maule, F., Porcù, E., Cani, A., Puppa, A. D., Trentin, L., Basso, G., et al. (2019) · Theranostics · doi:10.7150/thno.35882 · Cited by 56
Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
Vessoni, A. T., Filippi‐Chiela, E. C., Lenz, G., & Batista, L. F. Z. (2019) · Oncogene · doi:10.1038/s41388-019-1128-4 · Cited by 59
Notch signaling in lung cancer
Galluzzo, P., & Bocchetta, M. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.158 · Cited by 53
Lung Cancer Stem Cells and Implications for Future Therapeutics
Wang, J., Li, Z., White, J. R., & Zhang, L. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9844-4 · Cited by 53
Self-citationArsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth
Zhou, W., Cheng, L., Shi, Y., Ke, S. Q., Huang, Z., Fang, X., Chu, C.-W., Xie, Q., Bian, X., Rich, J. N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5836 · Cited by 57
Self-citation
Metadata
- Authors
- Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N.
- Affiliations
- Duke Medical Center (US)
- Cleveland Clinic (US)
- Corresponding author
- Rich, Jeremy N.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 15
- Issue
- 6
- Pages
- 501-513
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC2693960
- OpenAlex
- W2039075677
- Cited by
- 1,354
- References
- 65
- Citations by year
- 2026: 41 · 2025: 40 · 2024: 49 · 2023: 72 · 2022: 92 · 2021: 98 · 2020: 72 · 2019: 75 · 2018: 74 · 2017: 93 · 2016: 97 · 2015: 97 · 2014: 96 · 2013: 80 · 2012: 101
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 116659, R01CA116659, CA112958, R01CA129958)
- National Institute of Neurological Disorders and Stroke (K02NS047409, R01NS054276, NS054276, NS047409)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- HIF-2α, glioma stem cells, glioblastoma, hypoxia, angiogenesis, self-renewal, tumor initiation, cancer stem cell markers, patient survival, therapeutic target
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Brain Neoplasms, Cell Survival, Cells, Cultured, Glioblastoma, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Stem Cells, Biomarkers, Tumor, Neoplastic Stem Cells, Cell Hypoxia, Vascular Endothelial Growth Factor A, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
